Bococizumab is a novel anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a key regulator of cholesterol amounts. By blocking the activity https://rajangvrt009813.wikicommunications.com/user